Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-25-017620
Filing Date
2025-05-07
Accepted
2025-05-07 07:53:43
Documents
5
Period of Report
2025-05-07

Document Format Files

Seq Description Document Type Size
1 6-K ef20048286_6k.htm 6-K 12881
2 EXHIBIT 99.1 ef20048286_ex99-1.htm EX-99.1 548424
3 EXHIBIT 99.2 ef20048286_ex99-2.htm EX-99.2 252173
4 EXHIBIT 99.3 ef20048286_ex99-3.htm EX-99.3 279300
5 image00001.jpg GRAPHIC 3192
  Complete submission text file 0001140361-25-017620.txt   1098371
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 25919366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)